Pharmaceutical Headlines for 31 may 2011 ( Tuesday ) !

• AVEO Pharmaceuticals, Inc. (AVEO) Enters into Worldwide License Agreement with Centocor Ortho Biotech Inc.; AVEO Receives $15 Million; Eligible for up to $540 Million More...

• AstraZeneca PLC (AZN), Heptares In Study Pact Targeting GPCR Drugs;Heptares to Receive $6.25 Million Upfront More...

• Generex Biotechnology Corporation (GNBT) in Agreement to License RapidMist(TM) Technology for $10 Million to Amarantus BioSciences for Use With Its Proprietary MANF Proteins More...

• Deinove Achieves The First Key Milestone In The Deinol Project And Receives E1.6 Million From OSEO More...

• SAIC-Frederick, Inc. (SAI) and Biomatrica Collaborate to Improve Molecular Analysis in Cancer Research More...

• Future Bleak for Renovo Group Plc (RNVO.L) With No Workers or Products More...

• JB Chemicals & Pharmaceuticals Limited to Hire About 800 Medical Representatives in 2 Years More...




• Intrexon Corporation Raises $100 Million for Synthetic Biology InitiativesMore...

• Excelimmune, Inc. Completes $10.5 Million Series B Financing More...

• EpiCept Corporation (EPCT) Obtains New $10.6 Million Secured Debt Financing More...

• Ashland to Acquire International Specialty Products More...

• A New Chief Executive Officer to Strengthen BioAlliance Pharma's Growth More...

• Segal Institute for Clinical Research Announces Appointment of Dr. Leslie Penny Moldauer as Corporate Chief Medical Officer More...

• Enzo Biochem (ENZ) Names Ana I. Stancic Chief Financial Officer More...

• Peregrine Pharmaceuticals, Inc. (PPHM) Appoints Jeffrey Masten as Vice President, Quality as Company Advances Phase II Clinical Programs More...

• Derycz Scientific Hires AstraZeneca PLC (AZN) Executive to Drive Global Sales Growth More...

• Acasti Pharma Year End Results More...

• Medicago, Inc. Announces 2011 First Quarter Results More...

• Triclinic Labs Adds New Laboratory Space and Chemical Development Capabilities More...

• Sanofi (France) (SASY.PA)'s Diabetes Drug Cuts Blood Sugar, Weight-Study More... 

• Eli Lilly and Company (LLY) Presents Data on Cixutumumab in Five Subtypes of Sarcomas More... 

• UCB Group (UCBJF.PK) Release: New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V More... 

• Aegerion Pharmaceuticals, Inc. Announces Phase III 56-Week Data in HoFH Patients Taking Investigational Lomitapide is Consistent With 26-Week Data More... 

• Teva Pharmaceutical Industries Limited (TEVA) Announces Data on Granulocyte Colony Stimulating Factor Compounds for the Prevention of Chemotherapy-Induced Neutropenia in Breast Cancer Patients More...

• FDA Approves Optimer Pharmaceuticals, Inc. (OPTR)'s Dificid, a Treatment For Clostridium Difficile Infection More... 

• FDA Approves Oceana Therapeutics's Solesta(R); Novel Specialty Therapeutic Addresses Large Treatment Void for Patients with Life-Altering Fecal (Bowel) Incontinence More...

• Affymax, Inc. (AFFY) and Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Announce the Submission of a New Drug Application for Peginesatide for the Treatment of Anemia Associated with Chronic Renal Failure in Patients on Dialysis More...

• No Link Between Stress and MS in Women, According to University of Bergen Study More... 

• Combo of Paxil, Pravachol May Raise Blood Sugar, Stanford University Study More... 

• Bacteria Police Keep Cheaters in Line, Proceedings of the National Academy of Sciences Study More... 

• Drug Can Reverse Overgrown Hearts to Help Prevent Heart Failure, UT Southwestern Medical Center Researchers Find More... 

• Mutated Muscle Protein Causes Deafness, Max Planck Institute Research More...

( Source: Biospace )

Posted in: Daily,Pharma Hub